TY - JOUR
T1 - Increased leptin-b expression and metalloprotease expression contributed to the pyridoxine-associated toxicity in zebrafish larvae displaying seizure-like behavior
AU - Chen, Po Yuan
AU - Tsai, Yi Wen
AU - Chang, Alice YW
AU - Chang, Hui Hua
AU - Hsiao, Ya Hsin
AU - Huang, Chin Wei
AU - Sung, Pi Shan
AU - Chen, Bing Hung
AU - Fu, Tzu Fun
N1 - Funding Information:
This work was supported by the research grants ( MOST 106–2311-B-006–004-MY3) to TFF and (MOST 106–2320-B-006–053; MOST 107–2320-B-006–017 MOST 108–2320-B-006–005) to HHC and TFF funded by the Ministry of Science and Technology, Taiwan .
Funding Information:
This work was supported by the research grants (MOST 106?2311-B-006?004-MY3) to TFF and (MOST 106?2320-B-006?053; MOST 107?2320-B-006?017 MOST 108?2320-B-006?005) to HHC and TFF funded by the Ministry of Science and Technology, Taiwan.
Publisher Copyright:
© 2020
PY - 2020/12
Y1 - 2020/12
N2 - Epilepsy is a common neurological disorder affecting people of all ages, races and ethnic backgrounds world-wide. Vitamin B6 supplementation has been widely used as an adjuvant for treating epilepsy. However, the adverse effects, including nausea and peripheral sensory neuropathy, caused by long-term and high-dose consumption of vitamin B6 have undermined the usefulness of vitamin B6 supplementation, justifying additional experimental scrutiny of vitamin B6-associated toxicity. In the current study, we found that the presence of pyridoxine, the inactive form of B6 vitamer included in most nutrient supplements, increased the mortality of the larvae displaying chemical-induced epilepsy. The expression of leptin-b, one zebrafish ortholog of human leptin, was significantly increased in the larvae displaying seizures. Increased leptin-b expression alleviated larval seizure-like behavior when exposed to epilepsy inducer, but also increased larval mortality in the presence of pyridoxine. Meanwhile, elevated adam17 and mmp13 mRNA level were found in the larvae simultaneously exposed to epilepsy-inducer and pyridoxine. Adding TNF-α inhibitor and mmp13 inhibitor effectively improved the survival of larvae injected with leptin-b mRNA and exposed to pyridoxine subsequently. We conclude that increased leptin-b and metalloprotease expression contributed, at least partly, to the pyridoxine-associated toxicity observed in larvae displaying seizures.
AB - Epilepsy is a common neurological disorder affecting people of all ages, races and ethnic backgrounds world-wide. Vitamin B6 supplementation has been widely used as an adjuvant for treating epilepsy. However, the adverse effects, including nausea and peripheral sensory neuropathy, caused by long-term and high-dose consumption of vitamin B6 have undermined the usefulness of vitamin B6 supplementation, justifying additional experimental scrutiny of vitamin B6-associated toxicity. In the current study, we found that the presence of pyridoxine, the inactive form of B6 vitamer included in most nutrient supplements, increased the mortality of the larvae displaying chemical-induced epilepsy. The expression of leptin-b, one zebrafish ortholog of human leptin, was significantly increased in the larvae displaying seizures. Increased leptin-b expression alleviated larval seizure-like behavior when exposed to epilepsy inducer, but also increased larval mortality in the presence of pyridoxine. Meanwhile, elevated adam17 and mmp13 mRNA level were found in the larvae simultaneously exposed to epilepsy-inducer and pyridoxine. Adding TNF-α inhibitor and mmp13 inhibitor effectively improved the survival of larvae injected with leptin-b mRNA and exposed to pyridoxine subsequently. We conclude that increased leptin-b and metalloprotease expression contributed, at least partly, to the pyridoxine-associated toxicity observed in larvae displaying seizures.
UR - http://www.scopus.com/inward/record.url?scp=85094808505&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85094808505&partnerID=8YFLogxK
U2 - 10.1016/j.bcp.2020.114294
DO - 10.1016/j.bcp.2020.114294
M3 - Article
C2 - 33080184
AN - SCOPUS:85094808505
SN - 0006-2952
VL - 182
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
M1 - 114294
ER -